SCHEMBL6446934

SCHEMBL6446934

O=C(NCc1ccco1)Oc1ccc(F)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
CYP2C9 P11712 2/20 0.46
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
KCNH2 Q12809 1/20 0.41
RAB9A P51151 1/20 0.39
PKM P14618 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6442987 0.89 CYP2C9 (0.49) ALDH1A1CYP2C9CYP3A4CYP2D6CYP1A2
SCHEMBL6445354 0.86 CYP2C9 (0.50) ALDH1A1CYP2C9CYP3A4CYP2D6CYP1A2
SCHEMBL6441328 0.86 CYP2C9 (0.46) ALDH1A1CYP2C9CYP3A4HSD17B10CYP2D6
SCHEMBL6442104 0.84 CYP2C9 (0.53) ALDH1A1CYP2C9CYP3A4CYP2D6CYP1A2
SCHEMBL6440978 0.83 CYP2C9 (0.54) ALDH1A1CYP2C9CYP3A4CYP2D6CYP1A2
SCHEMBL6442418 0.83 CYP2C9 (0.51) ALDH1A1CYP2C9CYP3A4HSD17B10CYP2D6
SCHEMBL6444101 0.83 CYP2C9 (0.56) ALDH1A1CYP2C9CYP3A4HSD17B10CYP2D6
SCHEMBL6443286 0.83 CYP2C9 (0.49) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL6442978 0.83 CYP2C9 (0.51) ALDH1A1CYP2C9CYP3A4HSD17B10CYP2D6
SCHEMBL6445721 0.82 CYP2C9 (0.45) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed